Evidence map›Paper›PMID 22801444›Full record

ReviewCurrent opinion in nephrology and hypertension2012

Management approaches to hypertension in autonomic failure.

Amy C Arnold, Italo Biaggioni

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Current opinion in nephrology and hypertension, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00223691 phase1completednot on this map

Evaluation and Treatment of Autonomic Failure.

TypeinterventionalSponsorVanderbilt UniversityRan2002 to 2017Enrolled389ConditionsAutonomic Failure, Orthostatic HypotensionArmsAtomoxetine, Acarbose, Pyridostigmine Bromide, Yohimbine, Midodrine HCl
NCT00223717 phase1completednot on this map

The Pathophysiology and Treatment of Supine Hypertension in Patients With Autonomic Failure

TypeinterventionalSponsorVanderbilt UniversityRan2001 to 2017Enrolled152ConditionsHypertensionArmsClonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox), Desmopressin (DDAVP), Sildenafil
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Evaluation and treatment of orthostatic hypotension.Journal of the American Society of Hypertension : JASH
    Guideline
  2. Trial
  3. Article
  4. The power of positioning: managing severe autonomic dysreflexia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Dysautonomia: A Forgotten Condition - Part II.Arquivos brasileiros de cardiologia · 2021
    Article
  9. Pharmacologic treatment of orthostatic hypotension.Autonomic neuroscience : basic & clinical · 2020
    Review
  10. Review
  11. Management of Orthostatic Hypotension.Continuum (Minneapolis, Minn.) · 2020
    Review
  12. Orthostatic Hypotension in Parkinson Disease.Clinics in geriatric medicine · 2020
    Review
  13. Review
  14. Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2019
    Review
  15. Article
  16. Article
  17. Review
  18. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Movement disorders : official journal of the Movement Disorder Society · 2018
    Review
  19. Review
  20. Clinical characteristics of supine hypertension in de novo Parkinson disease.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amy C ArnoldDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA.
Italo Biaggioni
Vanderbilt University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Structural genomics of norepinephrine transportersP01HL056693 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROBERTSON, DAVID HERLIE · 1997 to 2016
$30.8M
Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROBERTSON, DAVID HERLIE · 2009 to 2018
$11.6M
Adenosine and Nitric Oxide DeficiencyR01HL067232 · NHLBI · VANDERBILT UNIVERSITY · PI BIAGGIONI, ITALO · 2001 to 2004
$1.1M
NCRR NIH HHS UL1 RR024975NHLBI NIH HHS HL 056693-16NHLBI NIH HHS P01 HL056693NHLBI NIH HHS R01 HL067232NINDS NIH HHS U54 NS065736NINDS NIH HHS U54NS065736-03PHS HHS UL1 UL1 TR000445
6 · The paper itself

Abstract

purpose of reviewSupine hypertension is a common finding in autonomic failure that can worsen orthostatic hypotension and predispose to end-organ damage. This review focuses on nonpharmacologic and pharmacologic approaches to manage hypertension in these patients in the face of disabling orthostatic hypotension. RECENT

findingsThe hypertension of autonomic failure can be driven by sympathetic-dependent or independent mechanisms, contingent on the site of autonomic lesions. Management of supine hypertension should include simple nonpharmacologic approaches including avoiding the supine position during the daytime and sleeping in a head-up tilt position at night. Most patients, however, require pharmacologic treatment. Several antihypertensive therapies lower nighttime pressure in autonomic failure, but none improve nocturnal volume depletion or morning orthostatic tolerance. Regardless, treatment may still be beneficial in some patients but must be decided on an individual basis. Blood pressure monitoring is helpful in this regard, as well as titration of doses, as these patients are hypersensitive to depressor agents due to loss of baroreceptor reflexes. SUMMARY: Autonomic failure provides a unique opportunity to study blood pressure regulation independent of autonomic influences. Understanding mechanisms driving supine hypertension will have important implications for the treatment of autonomic failure and will improve our knowledge of cardiovascular regulation in other populations, including essential hypertension and elderly hypertensive individuals with comorbid orthostatic hypotension.

Indexed as

Autonomic Nervous System DiseasesBlood PressureHumansHypertensionSupine PositionVasodilator AgentsVasodilator Agents

Identifiers

PMID22801444
PMCPMC3732047
OpenAlexW1977029823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.